SMN2 and proximal spinal muscular atrophy: Our in-depth molecular profiling thus demonstrates for the first time, to the best of our knowledge, that increasing FL SMN2 in neonatal SMA mice almost completely normalizes muscle transcripts and proteins, highlighting at the molecular level the potential treatment benefits arising from early intervention.